Odonate Therapeutics, Inc. (ODT): Price and Financial Metrics
GET POWR RATINGS... FREE!
ODT Stock Price Chart Interactive Chart >
ODT Price/Volume Stats
|Current price||$3.21||52-week high||$7.10|
|Prev. close||$3.22||52-week low||$2.80|
|Day high||$3.23||Avg. volume||2,289,387|
|50-day MA||$3.36||Dividend yield||N/A|
|200-day MA||$3.98||Market Cap||123.59M|
Odonate Therapeutics, Inc. (ODT) Company Bio
Odonate Therapeutics, LLC develops therapeutics to enhance the lives of patients with cancer in the United States. It is developing Tesetaxel, a novel chemotherapy agent that has completed Phase II clinical trials for patients with advanced or metastatic breast cancer. The company was founded in 2013 and is based in San Diego, California.
Most Popular Stories View All
ODT Latest News Stream
|Loading, please wait...|
ODT Latest Social Stream
View Full ODT Social Stream
Latest ODT News From Around the Web
Below are the latest news stories about Odonate Therapeutics Inc that investors may wish to consider to help them evaluate ODT as an investment opportunity.
SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm
SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma, Inc., Eargo, Inc., and Corcept Therapeutics, Inc. If you are a current owner of shares of any of these stocks, contact [email protected] or call (619) 708-3993. Odonate Therapeutics, Inc. (NASDAQ: ODT) Accused of Misleading Investors On August 4, 2021, Judge Marilyn Huff. of the United States District Court f
Looking at Odonate Therapeutics, Inc.'s ( NASDAQ:ODT ) insider transactions over the last year, we can see that...
ODONATE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Odonate Therapeutics, Inc. - ODT
NEW ORLEANS, August 21, 2021--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Odonate Therapeutics, Inc. (NasdaqGS: ODT).
Update in Lawsuit for Investors in Odonate Therapeutics, Inc. (NASDAQ:ODT) Announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / August 17, 2021 / The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in (NASDAQ:ODT) shares.
PHILADELPHIA, PA / ACCESSWIRE / August 16, 2021 / Kaskela Law LLC announces that it is investigating Odonate Therapeutics, Inc. ("Odonate" or the "Company") (Nasdaq:ODT).
ODT Price Returns